© All rights reserved to Barnea Jaffa Lande & Co. Law offices

Together is global

Together is global

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea‘s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompasses drafting applications for government support, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements; clinical trial agreements with research institutes, academic institutions, and hospitals; and more.

 

In addition, we counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology transfer companies in academic institutions and hospitals, and medical equipment companies. 

 

Back to Technology

News and updates - Technology / Life Sciences:


July 16, 2019

Femtech Meetup at Barnea

Our firm hosted today a meetup for entrepreneurs in the femtech field. Co-hosting was 50inTech, a French organization that provides a platform for women in the high-tech industry.

During the meetup, in which 25 entrepreneurs gathered, Ariella Dreyfuss delivered a brief overview of challenges, trends, and opportunities in the femtech field.

 

July 9, 2019

Femtech: The High-Tech Market Ignored and Then Discovered Was Worth Tens of Billions

Adv. Ariella Dreyfus, a partner in our firm who has advised startups in the femtech field, was interviewed by TheMarker for an article on the burgeoning femtech market. This market is estimated to reach a value of USD 50 billion in 2025.

June 27, 2019

Barnea Represented Johnson & Johnson Innovation in an Investment Round in DayTwo

Our firm represented JJDC in its follow on investment in the Israeli medtech company DayTwo, as part of a $31 million series B round.  

Technology / Life Sciences

Our team has extensive experience in advising Israeli and foreign companies in the fields of biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging and more

Barnea‘s activities in the healthcare sector include providing ongoing legal support from the R&D stage through to the finished product. This encompasses drafting applications for government support, protecting and building an intellectual property strategy, and advising on compliance with regulatory reporting requirements. We also prepare various agreements for clients, including cooperation agreements; clinical trial agreements with research institutes, academic institutions, and hospitals; and more.

 

In addition, we counsel clients in this sector on investment agreements, capital raising, and purchase transactions, as well as vis-à-vis investors.

 

The firm represents both Israeli and international entrepreneurs, venture capital funds, private funds, technology transfer companies in academic institutions and hospitals, and medical equipment companies. 

 

Back to Technology

News and updates - Technology:


July 16, 2019

Femtech Meetup at Barnea

Our firm hosted today a meetup for entrepreneurs in the femtech field. Co-hosting was 50inTech, a French organization that provides a platform for women in the high-tech industry.

During the meetup, in which 25 entrepreneurs gathered, Ariella Dreyfuss delivered a brief overview of challenges, trends, and opportunities in the femtech field.

 

July 9, 2019

Femtech: The High-Tech Market Ignored and Then Discovered Was Worth Tens of Billions

Adv. Ariella Dreyfus, a partner in our firm who has advised startups in the femtech field, was interviewed by TheMarker for an article on the burgeoning femtech market. This market is estimated to reach a value of USD 50 billion in 2025.

June 27, 2019

Barnea Represented Johnson & Johnson Innovation in an Investment Round in DayTwo

Our firm represented JJDC in its follow on investment in the Israeli medtech company DayTwo, as part of a $31 million series B round.  

Enter your email for newsletter sign up: